Pediatric Cancer Drug Testing Coordinating Center
Official title: Pediatric Oncology In Vivo Testing Program Coordinating Center
Funded at Jackson Laboratory · NIH-11537642 · Data updated 2026-11-12
A coordinating center is coordinating how young patients’ cancer models are tested with targeted drugs to help improve pediatric cancer outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jackson Laboratory NIH-funded |
| Lab location | 1 site (Bar Harbor, United States) |
| Project start | August 25, 2021 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $403,496 |
| NIH project number | 3U24CA263963-05S1 |
| Project ID | NIH-11537642 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are pediatric patients or pediatric cancer models where research findings could inform future trials or therapies.
✕Less likely to help
Patients not eligible for pediatric in vivo testing or without pediatric cancer involvement may not directly benefit.
What this research studies
This grant supports a coordinating center that manages in vivo testing of anti-cancer drugs for children, aligning adult and pediatric research to speed translation. It brings together experts in cancer models, data management, informatics, and multi-site collaboration to standardize testing and share results. By coordinating public-private partnerships, the project aims to streamline decision making and ensure timely, consistent testing across sites for pediatric oncology. The center focuses on ensuring safe, effective evaluation of targeted agents in pediatric contexts while meeting updated U.S. requirements.
Why it matters
Potential benefit: If successful, the program could accelerate the availability of effective targeted therapies for children with cancer.
How similar studies have gone: Similar multi-site in vivo testing programs have shown that standardized testing can improve the relevance and speed of translating agents to pediatric trials.
Where this research is happening
-
Jackson Laboratory
Bar Harbor, United States Active
Researchers
- Principal investigator: Bult, Carol J — Jackson Laboratory
- Study coordinator: Bult, Carol J
Related research
Other NIH-funded projects on the same topics.
-
Mouse Phenome Project: a shared mouse data resource for understanding human disease
A large, centralized database of mouse phenotypes is created to help researchers study human diseases by comparing mouse and human biology.
-
Increasing the usefulness of pediatric genomic medicine with Exomiser
A pediatric genetic diagnosis project is improving how we use sequencing data to find rare disease causes in children.
-
Modeling Hearing and Balance Disorders in Mice: HEar@JAX Workshop
A five-day workshop at The Jackson Laboratory trains researchers in using mouse models to study hearing and balance, with hands-on labs for 20 participants.
-
Age-stratified gut-on-a-chip model to study microbiome-driven aging of the lining of the intestine
A human gut-on-a-chip model will be created to study how aging-related changes in the gut lining interact with microbiome shifts, using patient-derived tissues and age-appropriate microbes.
-
Single-cell long-read sequencing to map cancer RNA variants
A cancer research grant aims to make advanced single-cell RNA sequencing more accurate and widely usable to understand how different RNA isoforms affect brain and breast cancers.
-
PDX Data Commons and Coordination Center for patient-derived cancer models
A national effort to share and analyze patient-derived cancer models to find effective drug combinations for specific cancer patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.